Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link

Opportunity	Posted	Closing
U.S. Nuclear Regulatory Commission Funding Opportunity Announcement (FOA), Scholarship and Fellowship Education Grant, Faculty Development Grant, and Trade School and Community College Scholarship Grant, Fiscal Year (FY) 2020 Agency: NRC	02/10/20	04/10/20
Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	02/06/20	06/29/20
Naval Service Warfare Center (NSWC) Crane Office-Wide Agency: CRANE	02/03/20	03/04/20
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC	02/03/20	07/28/22
Centers for AIDS Research (P30 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC	02/03/20	07/28/22
Reproducible Cells and Organoids via Directed- Differentiation Encoding Agency: NSF	02/01/20	04/30/20
National and State Tobacco Control Program Agency: NCCDPHP	01/28/20	04/03/20
Resource Networks for Protein Polymorphisms in Alzheimers Disease and its Related Dementias (AD/ADRD) (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NIA	01/27/20	06/17/20
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/27/20	05/07/23
FY2020 Research Opportunities in Accelerator Stewardship Agency: SC	01/24/20	04/03/20
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) (UG3/UH3, Clinical Trials Optional) Agency: NIH Institutions: NCCIHNIANIAMSNICHDNIDCRNINDSNINRNIMHDNCATSNCIOBSSR	01/23/20	03/30/20
HIV/AIDS and the Tumor Niche (U54 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	01/23/20	04/15/20
Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required) Agency: NIH Institutions: NIDDKNIANCI	01/23/20	04/22/20
Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required) Agency: NIH Institutions: NIDDKNIANCI	01/23/20	04/22/20
Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/23/20	11/18/20
Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNEINIMHNINDSNCI	01/23/20	05/26/22
HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) Agency: NIH Institutions: NINDSNIAAANIAMSNICHDNIDCRNIDANINRNIMHDNCCIHNCIOBSSR	01/21/20	03/24/20
Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed) Agency: NIH Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI	01/17/20	05/08/23
Biomedical Data Repository (U24 - Clinical Trials Not Allowed) Agency: NIH Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI	01/17/20	05/08/23
HIGH-ENERGY-DENSITY LABORATORY PLASMA SCIENCE Agency: SC	01/16/20	03/16/20
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/16/20	11/17/20
Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/16/20	11/17/20
Public Health and Health Systems Partnerships to Increase Colorectal Cancer Screening in Clinical Settings Agency: NCCDPHP	01/14/20	03/17/20
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	01/14/20	04/01/22
Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	01/14/20	04/01/22
American Indian Air Quality Training Program Agency: EPA	01/13/20	03/13/20
Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	01/10/20	03/19/20
Innovative, Comprehensive, Cost-effective and Locally Sustainable Community and Facility HIV Prevention, Care and Treatment Services for Epidemic Control in the Republic of Zimbabwe under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	01/09/20	03/09/20
Namibia Mechanism for Public Health Assistance, Capacity, and Technical Support II (NAM-PHACTS II) under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	01/08/20	03/11/20
Supporting the Provision of Quality Cervical Cancer Screening and Pre-Cancer Treatment Services for Women Living with HIV in Botswana under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	01/07/20	03/09/20
Support Government of the Kingdom of Eswatini (GKoE) to Provide Comprehensive, Quality Assured Care, Treatment and Prevention HIV/TB Services to Achieve and Sustain Epidemic Control under the President's Emergency Plan for AIDS Relief (PEPFAR) Agency: CGH	01/07/20	03/11/20
Health Promotion and Disease Prevention Research Centers: 2020 Special Interest Project Competitive Supplements (SIPS) Agency: HHSCDCERA	12/23/19	02/25/20
Methods and Measurement in Research with Sexual and Gender Minority (SGM) Populations (R21- Clinical Trials Not Allowed) Agency: NIH Institutions: NIMHDNIMHSGMRONCIODP	12/23/19	03/13/20
DoD Breast Cancer, Era of Hope Scholar Award Agency: AMRAA	12/23/19	03/26/20
DoD Breast Cancer, Breakthrough Award Levels 1 and 2 Agency: AMRAA	12/23/19	03/26/20
DoD Breast Cancer, Innovator Award Agency: AMRAA	12/23/19	06/24/20
DoD Breast Cancer, Breakthrough Award Level 3 Agency: AMRAA	12/23/19	06/24/20
DoD Breast Cancer, Breakthrough Award Level 4 Agency: AMRAA	12/23/19	06/24/20
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/20/19	09/29/20
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/20/19	09/29/20
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Agency: NIH Institutions: NCI	12/20/19	09/29/20
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/20/19	09/29/20
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/20/19	09/29/20
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/20/19	09/29/20
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/10/19	10/28/22
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	12/09/19	09/07/22
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	12/04/19	09/29/20
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	12/04/19	09/29/20
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	12/04/19	09/29/20
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	12/04/19	09/29/20
Co-infection and Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/22/19	01/07/23
Co-infection and Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/22/19	01/07/23
NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	11/22/19	01/07/23
Atmospheric System Research (ASR) Agency: SC	11/20/19	03/10/20
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Required) Agency: NIH Institutions: NCI	11/19/19	02/26/20
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/19/19	02/26/20
Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	11/12/19	05/11/21
Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	11/12/19	01/07/23
NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/08/19	01/07/23
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/04/19	09/25/21
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional) Agency: NIH Institutions: FICNIAMSNIDDKNIMHNCI	10/18/19	12/03/20
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/18/19	01/07/23
Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCI	10/18/19	11/07/22
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI	10/04/19	09/08/22
HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI	10/04/19	09/08/22
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI	10/04/19	09/08/22
HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI	10/04/19	09/08/22
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/02/19	01/07/23
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	10/02/19	01/07/23
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: OPPNETNEINIANIAAANIAMSNICHDNIDCDNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR	09/18/19	03/17/21
Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) Agency: NIH Institutions: OPPNETNEINIANIAAANICHDNIDCDNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR	09/18/19	03/17/21
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: FICNIBIBNICHDNIDCDNIMHNINDSNCIOBSSRORWH	09/13/19	12/03/20
Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/13/19	07/31/20
Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNHLBINIDCRNCI	09/12/19	01/07/23
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANIAAA	09/09/19	09/07/21
Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed) Agency: NIH Institutions: NHLBINCINIANIAID	09/09/19	01/14/22
Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/06/19	06/23/21
Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/05/19	06/23/21
Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/05/19	06/23/21
Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/05/19	06/23/21
Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	09/05/19	06/23/21
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/05/19	05/07/21
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	09/03/19	01/10/22
Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	09/03/19	01/10/22
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	07/16/22
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/29/19	09/07/22
Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/29/19	03/11/22
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/28/19	07/20/22
Neural Regulation of Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/28/19	05/27/22
Neural Regulation of Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/28/19	05/27/22
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	08/16/19	07/16/22
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/16/19	06/08/22
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/16/19	06/08/22
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	08/16/19	09/07/22
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/12/19	06/08/22
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/12/19	06/08/22
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNCATS	08/05/19	04/05/22
Human Exploration Research Opportunities (HERO) Agency: JSC	07/31/19	09/04/20
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	07/30/19	07/30/20
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	07/30/19	02/11/22
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) Agency: NIH Institutions: NCI	07/26/19	07/30/20
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINHLBINIAAANIDANIEHSCTP	07/08/19	03/08/21
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	06/28/19	01/14/22
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/19	09/07/22
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Agency: NIH Institutions: NIA	06/25/19	07/16/22
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIA	06/25/19	07/16/22
Interaction of Ionizing Radiation with Matter University Research Alliance (IIRM-URA) Agency: DTRA	05/30/19	09/30/20
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/22/19	11/15/21
Postdoctoral Research Associate Training (PRAT) Program (Fi2) Agency: NIH Institutions: NIGMS	05/21/19	10/04/21
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Agency: NIH Institutions: FICNCINIDANIMH	05/14/19	08/20/21
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/13/19	11/15/20
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/13/19	11/15/20
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/08/19	10/08/21
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH	05/08/19	05/07/22
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH	05/08/19	05/07/22
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH	05/08/19	05/07/22
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	05/07/19	04/06/20
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH	05/07/19	04/06/20
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	05/07/19	04/06/20
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH	05/07/19	04/06/20
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/01/19	12/10/21
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIEHS	04/11/19	11/08/21
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIEHS	04/11/19	11/08/21
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/08/19	06/17/21
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/13/19	10/18/20
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH	02/28/19	05/07/22
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH	02/28/19	05/07/22
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/27/19	11/08/21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/27/19	11/08/21
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDORIP	02/22/19	01/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) Agency: NIH Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINDSNLMORIP	02/22/19	01/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Agency: NIH Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNIMHD	02/22/19	01/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNIMHDNINDSNLMORIP	02/22/19	01/07/22
Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/22/19	05/07/22
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/22/19	05/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) Agency: NIH Institutions: NCINHLBINIANIAAANIAMSNIDCRNIEHS	02/21/19	01/07/22
Biology of Bladder Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/19	05/07/22
Biology of Bladder Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/19	05/07/22
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/24/19	08/03/20
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) Agency: NIH Institutions: NIDANIMHDNIMHNCINCCIHORWH	01/09/19	09/07/21
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) Agency: NIH Institutions: NIDANINDSNIMHDNIMHNCINICHDORWH	01/09/19	09/07/21
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) Agency: NIH Institutions: NIBIBNCINIANIAAANINDS	01/08/19	05/07/21
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIA	01/08/19	01/07/22
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/08/19	01/07/22
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIAMS	01/08/19	01/07/22
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	01/08/19	01/07/22
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	12/21/18	01/07/22
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) Agency: NIH Institutions: NINRNCINIANICHDNIDCDNIDANIMHNINDSNHLBI	12/21/18	01/07/22
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINHLBINIANIAIDNIAMSNIBIBNICHDNIDCDNIDANIEHSNIMHNINDSNCCIHNINR	12/21/18	01/07/22
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) Agency: NIH Institutions: NICHDNEININRNIDCDNIDANINDSNHLBINCINIANIMH	12/21/18	01/07/21
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNCCIHNIEHS	12/20/18	01/07/22
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIH	12/20/18	01/07/22
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIH	12/20/18	01/07/22
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIH	12/20/18	01/07/22
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for Non-PEPFAR (President's Emergency Plan for AID Relief) Funded Countries Agency: SUP	12/13/18	09/30/20
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/12/18	07/30/20
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH	12/11/18	11/04/20
HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH	12/10/18	02/22/21
HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH	12/10/18	02/22/21
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed) Agency: NIH Institutions: NIBIBNIAAANIAMSNCINEINICHDNIDCRNIDDKNIDANINDSNCCIHNCATS	12/10/18	02/22/21
HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH	12/10/18	02/22/21
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCIOBSSR	11/28/18	03/04/21
Research Project Grant (Parent R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPICs	11/05/18	01/07/22
Emerging Global Leader Award (K43 Independent Clinical Trial Required) Agency: NIH Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH	11/02/18	11/04/20
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIMHNLMNCATS	10/24/18	09/05/21
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIMHNLMNCATS	10/24/18	09/05/21
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIHNCATSNHLBIORIPNICHD	10/17/18	02/02/21
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	10/05/18	03/04/21
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	10/05/18	03/04/21
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH	10/05/18	04/15/21
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH	10/05/18	12/11/20
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINCCIHOBSSR	10/01/18	01/07/22
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINCCIHOBSSR	10/01/18	01/07/22
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINIAMSNCCIHOBSSR	10/01/18	01/07/22
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINIAMSNCCIHOBSSR	10/01/18	01/07/22
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/28/18	07/11/21
FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (President's Emergency Plan for AIDS Relief) Funded Countries Agency: SUP	09/28/18	09/30/20
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD	09/21/18	01/07/22
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINHLBINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIHOBSSRORWH	09/19/18	03/12/20
Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/12/18	05/07/20
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIDANCINCCIHNIAAANICHD	09/10/18	09/07/21
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/07/18	08/11/21
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/05/18	11/13/20
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP	08/22/18	09/07/21
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINCCIHODS	08/14/18	09/07/21
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/07/18	09/07/21
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/07/18	09/07/21
Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANINRNLMNCATSNCCIH	08/02/18	03/12/20
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIAMSNIDAODS	07/25/18	09/07/21
Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNIMHD	07/25/18	09/07/21
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	07/24/18	03/08/21
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNCCIH	07/17/18	09/07/21
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNINR	07/17/18	09/07/21
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINICHDODPOBSSR	07/12/18	09/10/21
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	06/29/18	06/25/21
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	06/29/18	06/25/21
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	06/29/18	06/15/21
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	06/29/18	06/15/21
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/18	06/14/21
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/18	09/10/20
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS	06/20/18	09/04/21
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNCINEI	06/14/18	06/03/21
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINEINHLBINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIEHSFICNCCIHORIP	06/05/18	04/15/20
Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINIDDKNIEHSNCCIH	06/05/18	04/15/20
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional) Agency: NIH Institutions: NCI	05/24/18	01/05/21
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) Agency: NIH Institutions: NCI	05/24/18	01/05/21
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNIBIBNCI	05/16/18	09/07/21
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/30/18	01/11/21
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) Agency: NIH Institutions: NIAIDNCINIMH	04/20/18	05/07/21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/29/18	11/19/20
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD	03/28/18	05/07/21
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH	03/28/18	05/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINICHDODS	03/27/18	05/07/21
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNCINEINIAAANIDCRNIDANINR	03/06/18	04/05/21
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/21/18	06/15/20
U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/21/18	06/15/20
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/13/18	11/19/20
Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	02/13/18	11/19/20
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNINDSNIMHDNLMNCCIHNCATSORIP	02/09/18	01/07/21
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/26/18	01/25/21
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed ) Agency: NIH Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP	01/25/18	09/07/21
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NCINIDCRNIBIB	12/21/17	01/07/21
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed Agency: NIH Institutions: FICNCI	12/21/17	03/06/20
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required Agency: NIH Institutions: FICNCI	12/21/17	03/06/20
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINCCIH	12/15/17	09/07/20
Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional) Agency: NIH Institutions: NIANINRNIMHDNCI	12/15/17	05/07/20
Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIANCCIHNINRNIMHDNCINHLBI	12/15/17	05/07/20
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/06/17	03/12/21
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Agency: NIH Institutions: NCI	12/06/17	03/12/21
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Research Experiences (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Courses for Skills Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/30/17	11/13/20
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR	11/29/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Agency: NIH Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR	11/29/17	09/07/20
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) Agency: NIH Institutions: NCINEINHGRINIANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHNHLBIORIPNINDSNIAAA	11/21/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) Agency: NIH Institutions: NCI	11/20/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Agency: NIH Institutions: NCI	11/20/17	01/07/21
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	01/07/21
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	01/07/21
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNIEHSODP	11/15/17	05/07/20
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNIANIDDKNIDANIDCRNINDSNCCIHNIMHDNCI	11/07/17	05/07/21
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCININRNIANIDANIDCRNINDSNCCIHNIMHD	11/07/17	05/07/21
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Agency: NIH Institutions: NCCIH	11/02/17	06/29/20
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCI	11/01/17	05/07/20
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials) Agency: NIH Institutions: NCI	10/31/17	01/07/21
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required) Agency: NIH Institutions: NCI	10/31/17	01/07/21
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/30/17	05/07/20
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH	10/17/17	01/07/21
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) Agency: NIH Institutions: NCINIDCR	10/12/17	01/07/21
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed Agency: NIH Institutions: NCI	10/12/17	10/08/20
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	10/12/17	10/08/20
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDANCCIH	10/10/17	01/07/21
Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	10/03/17	01/07/21
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/29/17	01/07/21
Research to Improve Native American Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNIDCR	09/29/17	05/14/20
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNINRNIDCR	09/29/17	05/14/20
Stimulating Access to Research in Residency (StARR) (R38) Agency: NIH Institutions: NHLBINCINIAIDNIA	08/23/17	05/12/20
Biology of Lung, and Head and Neck Preneoplasias (R21) Agency: NIH Institutions: NCI	08/16/17	01/07/21
Biology of Lung, and Head and Neck Preneoplasias (R01) Agency: NIH Institutions: NCI	08/15/17	01/07/21
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) Agency: NIH Institutions: NCI	08/04/17	09/07/20
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21) Agency: NIH Institutions: NCI	08/04/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03) Agency: NIH Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSFIC	08/01/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01) Agency: NIH Institutions: NHGRINCINIANICHDNIEHSNINDSNIMHD	08/01/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) Agency: NIH Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSNINDSNIMHD	08/01/17	09/07/20
Assay development and screening for discovery of chemical probes or therapeutic agents (R01) Agency: NIH Institutions: NCINIAIDNIDCDNIDANIMH	07/27/17	09/07/20
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01) Agency: NIH Institutions: NCI	07/20/17	09/07/20
Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01) Agency: NIH Institutions: NCI	07/20/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R21) Agency: NIH Institutions: NIANCINIAAANIAMSNIDCRNIDANIMHNIMHDNINDSNINR	06/23/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R01) Agency: NIH Institutions: NIANCINCCIHNIAMSNIDCRNIDANIMHNIMHDNINDSNINR	06/23/17	09/07/20
Integration of Individual Residential Histories into Cancer Research (R21) Agency: NIH Institutions: NCI	06/22/17	09/07/20
Integration of Individual Residential Histories into Cancer Research (R01) Agency: NIH Institutions: NCI	06/22/17	09/07/20
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01) Agency: NIH Institutions: NCI	05/16/17	09/07/20
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21) Agency: NIH Institutions: NCI	05/16/17	09/07/20
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) Agency: NIH Institutions: NCI	04/04/17	05/07/20
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) Agency: NIH Institutions: NCI	04/03/17	05/07/20
Innovative Research in Cancer Nanotechnology (IRCN) (R01) Agency: NIH Institutions: NCI	03/30/17	05/21/20
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) Agency: NIH Institutions: NCINHGRINIDCR	03/30/17	05/07/20
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) Agency: NIH Institutions: NCINHGRINIDCR	03/30/17	05/07/20
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Agency: NIH Institutions: NCI	03/29/17	05/07/20
Mechanisms of Alcohol-associated Cancers (R21) Agency: NIH Institutions: NIAAANCI	03/13/17	09/07/20
Mechanisms of Alcohol-associated Cancers (R01) Agency: NIH Institutions: NIAAANCI	03/13/17	09/07/20
Thermal Transport Processes Agency: NSF	02/22/17	08/17/20
Biophotonics Agency: NSF	02/22/17	08/17/20
HIV-1 infection of the Central Nervous System (R01) Agency: NIH Institutions: NIMHNIAAANIANIAIDNIDANINDS	01/05/17	05/07/20
Fertility Status as a Marker for Overall Health (R01) Agency: NIH Institutions: NICHDNIEHSODP	12/19/16	05/07/20
Fundamental Research to Counter Weapons of Mass Destruction Agency: DTRA	03/20/15	09/30/24

TOP